Ocular Evidence
Evidence database / Studies / kamiya-2021-eight-year-evo-icl
MODERATE evidenceRETROSPECTIVEVerified evidence

Eight-Year Outcomes of Implantation of Posterior Chamber Phakic Intraocular Lens With a Central Port for Moderate to High Ametropia

Kamiya K, Shimizu K, Takahashi M, Ando W, Hayakawa H, Shoji N · Frontiers in Medicine · 2021

Source
106enrolled patients*
177enrolled eyes*
1structured arms
2920maximum standardized days follow-up

* Descriptive sum of reported arm counts. “≥” indicates that one or more arm counts were not reported; missing values are not treated as zero.

Study arm

EVO ICL

ICLEVO Implantable Collamer Lens

Population

Patients
106
Eyes
177
Bilateral treatment
Not reported
Age range
Not reported
Sphere range
Not reported
Cylinder range
Not reported
Spherical equivalent
Not reported
Corneal thickness
Not reported

Eligibility definition

Inclusion
Moderate to high myopia or myopic astigmatism.

Exclusion
Not structured

Reported outcomes by follow-up

OutcomeFollow-upFollow-up sampleResultReported fractionProvenance
MRSE within ±0.50 D
predictability
8 years177 eyes83.0%denominator: 177 eyes
VERIFIED
Refraction within ±1.00 D
efficacy
8 years177 eyes93.0%denominator: 177 eyes
VERIFIED
Cataract requiring lens extraction or exchange
complications
8 years177 eyes1.7%3 / 177 eyes
VERIFIED
Efficacy index
efficacy
8 years177 eyes0.89Not reported
VERIFIED
Safety index
safety
8 years177 eyes1.18Not reported
VERIFIED

Complications

No structured complication observations are available for this arm. This means “not reported in this dataset,” not zero complications.